This invention provides compounds of the type (I) and their medically acceptable salts: (I) in which m, n, W, XY,G,R1, R2, R3 and R4 are as defined in the description for use in the treatment or prevention of diseases or conditions caused by the mediation of prednisin,such as psychiatric and neurological conditions.
展开▼